Empowering Innovation in Life Sciences and Healthcare

With its unique global platform, NovaQuest Capital Management promotes the development of life-saving drugs and healthcare technologies and services in order to reduce the cost of healthcare, address unmet medical needs, improve safety, and enhance overall quality of life.

About

NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and growth of next generation drugs, technologies and services.

NovaQuest Capital is headquartered in Raleigh, North Carolina.

Product Finance

Late-stage investments in global biopharmaceutical products

Learn more

Private Equity

Partnerships with healthcare technology and services companies

Learn more

Our Timeline

NovaQuest Capital Management has a long and proven history of life sciences and healthcare investing.

Our Roots

Quintiles Transnational (today IQVIA) is founded to conduct outsourced clinical pharmaceutical trials, growing to become a leading global partner in drug research, development, and data insights

NovaQuest Beginnings

NovaQuest forms as a strategic investment arm within Quintiles Transnational (now IQVIA), laying the foundation for the firm’s product finance and private equity strategies

Investing at Quintiles Transnational

NovaQuest invests over $1 billion across life sciences, pharmaceutical services, and technology

An Independent Firm

NovaQuest Capital becomes an independent firm, spinning out from Quintiles Transnational (IQVIA) to continue its investment strategy

Product Finance Fund III

NovaQuest Capital raises its first institutional fund with approximately $500 million in capital

Product Finance Fund IV

NovaQuest Capital raises approximately $900 million in capital

Platform Expansion

NovaQuest Capital formalizes separate Private Equity strategy and expands the investment team

Product Finance Fund V & Private Equity Fund I

NovaQuest Capital raises approximately $1.2 billion for Product Finance Fund V and $275 million for Private Equity Fund I in capital

NovaQuest Today

NovaQuest Capital continues to invest from its strategic platforms

Strategic Relationships

NovaQuest Capital’s expansive network of leading global healthcare partners brings unique operational and strategic advantages to the platform.

Hover on one of our partners to learn more

Clinical Research Organizations

Clinical research organization (CRO) provide biopharmaceutical development and commercial outsourcing services for Phase I-IV clinical trials as well as associated laboratory, analytical, and consulting services.

Mitsui & Co.

As one of the largest holding companies in the world, Japan-based Mitsui maintains a portfolio of more than 35 healthcare investments across a wide range of healthcare sub-sectors.

RTI International

RTI International is an independent, nonprofit research institute dedicated to improving the human condition. It combines scientific rigor and technical expertise in social and laboratory sciences, engineering, and international development to deliver solutions to the critical needs of clients worldwide.

Mycovia Pharmaceuticals

Mycovia Pharmaceuticals is developing breakthrough therapies in women’s health and dermatology.

Clinical Research Organizations

Clinical research organization (CRO) provide biopharmaceutical development and commercial outsourcing services for Phase I-IV clinical trials as well as associated laboratory, analytical, and consulting services.

HUYA Bioscience

Huya Biosciences has aggregated one of the most robust compound portfolios in China covering all major therapeutics areas.

The Latest

View All News